DK0731695T3 - Plaster indeholdende et aktivt stof - Google Patents

Plaster indeholdende et aktivt stof

Info

Publication number
DK0731695T3
DK0731695T3 DK95901413T DK95901413T DK0731695T3 DK 0731695 T3 DK0731695 T3 DK 0731695T3 DK 95901413 T DK95901413 T DK 95901413T DK 95901413 T DK95901413 T DK 95901413T DK 0731695 T3 DK0731695 T3 DK 0731695T3
Authority
DK
Denmark
Prior art keywords
active substance
pct
body temperature
membrane
reservoir
Prior art date
Application number
DK95901413T
Other languages
English (en)
Inventor
Reinhold Meconi
Frank Seibertz
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK0731695T3 publication Critical patent/DK0731695T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95901413T 1993-12-04 1994-11-23 Plaster indeholdende et aktivt stof DK0731695T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4341444A DE4341444C2 (de) 1993-12-04 1993-12-04 Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
PCT/EP1994/003866 WO1995015158A1 (de) 1993-12-04 1994-11-23 Wirkstoffhaltiges pflaster

Publications (1)

Publication Number Publication Date
DK0731695T3 true DK0731695T3 (da) 1999-03-01

Family

ID=6504235

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95901413T DK0731695T3 (da) 1993-12-04 1994-11-23 Plaster indeholdende et aktivt stof

Country Status (10)

Country Link
US (1) US5770220A (da)
EP (1) EP0731695B1 (da)
JP (1) JP3549888B2 (da)
AT (1) ATE165736T1 (da)
CA (1) CA2177970C (da)
DE (2) DE4341444C2 (da)
DK (1) DK0731695T3 (da)
ES (1) ES2118535T3 (da)
GR (1) GR3027575T3 (da)
WO (1) WO1995015158A1 (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19541260A1 (de) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut
DE19546024C2 (de) * 1995-12-09 1998-09-10 Lohmann Therapie Syst Lts Transdermale pharmazeutische Zubereitung und deren Herstellung
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
JP5334346B2 (ja) * 1999-08-10 2013-11-06 久光製薬株式会社 ロール状外用貼付剤
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
US6559180B2 (en) 2001-03-27 2003-05-06 Yuri Busiashvili Nitroglycerin-menthol potentiation for treatment of angina
DE10118282A1 (de) * 2001-04-12 2002-12-05 Lohmann Therapie Syst Lts Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke
MXPA03009603A (es) * 2001-04-20 2004-12-06 Johnson & Johnson Arreglo de microproyeccion que tiene un agente benefico que contiene un recubrimiento.
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2447302C (en) * 2001-05-01 2008-07-29 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
DE60233217D1 (de) 2001-05-01 2009-09-17 Corium Internat Inc Hydrogel-zusammensetzungen
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) * 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) * 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US8524200B2 (en) 2002-09-11 2013-09-03 The Procter & Gamble Company Tooth whitening products
CA2453013C (en) * 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
ES2437565T3 (es) * 2003-06-30 2014-01-13 Alza Corporation Formulaciones para microproyecciones revestidas que contienen contraiones no volátiles
EP1648363B1 (en) * 2003-07-03 2019-03-06 Corium International, Inc. Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
US7470266B2 (en) 2003-09-16 2008-12-30 I-Flow Corporation Fluid medication delivery device
CN102764247B (zh) 2004-01-30 2016-04-20 考里安国际公司 递送活性剂的快速溶解膜
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
RU2393877C2 (ru) * 2004-08-05 2010-07-10 Кориум Интернэшнл, Инк. Адгезивная композиция
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
DE102005050431A1 (de) * 2005-10-21 2007-04-26 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
BRPI0917862A2 (pt) * 2008-09-30 2015-11-24 Teikoku Pharma Usa Inc composições transdérmicas de donepezil com distribuição prolongada e métodos para usar as mesmas
EP2387394B1 (en) 2009-01-14 2018-05-02 Corium International, Inc. Transdermal administration of tamsulosin
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
RU2573293C2 (ru) 2010-03-26 2016-01-20 Филип Моррис Продактс С.А. Ингибирование раздражающих ощущений при потреблении некурительных табачных продуктов
EP2691058B1 (en) * 2011-03-29 2016-03-02 ResMed R&D Germany GmbH Cushion for patient interface
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
EP3906956B1 (en) * 2013-11-14 2023-10-25 ResMed Pty Ltd A patient interface
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
GB2561262B (en) * 2017-07-13 2019-03-20 Dentmed Ltd A targeted drug delivery pad
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations
DE102020214263A1 (de) 2020-11-12 2022-05-12 OPTIMA life science GmbH Vorrichtung und Verfahren zum Übertragen einer Membran

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
DE3503111A1 (de) * 1985-01-31 1986-08-07 Rainer K. Dr. 8022 Grünwald Liedtke Arzneipflaster
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
DE3522060A1 (de) * 1985-06-20 1987-01-08 Liedtke Pharmed Gmbh Arzneipflaster fuer systemische anwendungen
ES2028074T3 (es) * 1986-06-13 1992-07-01 Alza Corporation Activacion por humedad de un sistema de suministro transdermico de farmacos.
EP0249475A3 (en) * 1986-06-13 1989-10-11 Alza Corporation Delayed percutaneous delivery
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US4983395A (en) * 1987-11-12 1991-01-08 Theratech Inc. Device for administering an active agent to the skin or mucosa
US4877618A (en) * 1988-03-18 1989-10-31 Reed Jr Fred D Transdermal drug delivery device
US5008110A (en) * 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
DE3908431A1 (de) * 1989-03-15 1990-09-27 Lohmann Therapie Syst Lts Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung
US4963261A (en) * 1989-08-28 1990-10-16 Chromex Corp. Microporous membrane having a macroporous support
US5314694A (en) * 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset

Also Published As

Publication number Publication date
WO1995015158A1 (de) 1995-06-08
DE4341444C2 (de) 1996-03-14
DE4341444A1 (de) 1995-06-08
JP3549888B2 (ja) 2004-08-04
CA2177970C (en) 2006-01-10
ES2118535T3 (es) 1998-09-16
EP0731695A1 (de) 1996-09-18
JPH09505815A (ja) 1997-06-10
GR3027575T3 (en) 1998-11-30
CA2177970A1 (en) 1995-06-08
US5770220A (en) 1998-06-23
EP0731695B1 (de) 1998-05-06
DE59405920D1 (de) 1998-06-10
ATE165736T1 (de) 1998-05-15

Similar Documents

Publication Publication Date Title
DK0731695T3 (da) Plaster indeholdende et aktivt stof
DK0651635T3 (da) Plaster med aktivt stof til lavtsmeltende og/eller flygtige aktive stoffer
NO984458D0 (no) Transdermalt terapeutisk system med liten applikasjons-omrÕde tykkelse og stor fleksibilitet og fremgangsmÕte
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
DK0680319T3 (da) Nitroglycerin-holdigt plaster, fremgangsmåde til dets fremstilling og anvendelse heraf.
MY105074A (en) Transdermal therapeutical system comprising norpseudoephedrine as active component.
IL114949A0 (en) A transdermal layered therapeutic system containing estradiol and a process for the preparation thereof
ES2105334T3 (es) Sistema terapeutico percutaneo para la administracion de fisostigmina en la piel y el procedimiento para su obtencion.